The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

被引：0
|
作者：
Cunzhen Shi
Xiangqun Li
Xiaogan Wang
Ning Ding
Lingyan Ping
Yunfei Shi
Lan Mi
Yumei Lai
Yuqin Song
Jun Zhu
机构：
[1] Peking University Cancer Hospital & Institute,Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma
[2] Beijing Doing Biomedical Technology Co.,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology
[3] Ltd,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)
[4] Peking University Cancer Hospital & Institute,undefined
[5] Peking University Cancer Hospital & Institute,undefined
来源：
Journal of Hematology & Oncology | / 11卷
关键词：
Mer tyrosine kinase; Mantle cell lymphoma; Therapeutic target; UNC2250;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase
    Uddin, S
    Gardziola, C
    Dangat, A
    Yi, TL
    Platanias, LC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) : 833 - 838
  • [42] Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
    Rinaldi, A
    Kwee, I
    Taborelli, M
    Largo, C
    Uccella, S
    Martin, V
    Poretti, G
    Gaidano, G
    Calabrese, G
    Martinelli, G
    Baldini, L
    Pruneri, G
    Capella, C
    Zucca, E
    Cotter, FE
    Cigudosa, JC
    Catapano, CV
    Tibiletti, MG
    Bertoni, F
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (03) : 303 - 316
  • [43] Regulation and function of the proto-oncogene protein kinase B/Akt
    Hemmings, BA
    FEBS JOURNAL, 2005, 272
  • [44] A homozygous missense mutation in the tyrosine kinase domain of the RET proto-oncogene in an infant with total intestinal aganglionosis
    Shimotake, T
    Go, S
    Inoue, K
    Tomiyama, H
    Iwai, N
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (04): : 1286 - 1291
  • [45] Point mutation in the exon 12 of tyrosine kinase proto-oncogene of Ondine-Hirschsprung syndrome.
    Sakai, T
    Wakizaka, A
    Nirasawa, Y
    Itoh, Y
    Kurosawa, S
    Nagashima, Y
    Tobe, M
    FASEB JOURNAL, 1997, 11 (09): : A947 - A947
  • [46] Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples
    Zito Marino, Federica
    Rossi, Giulio
    Cozzolino, Immacolata
    Montella, Marco
    Micheli, Mariacarolina
    Bogina, Giuseppe
    Munari, Enrico
    Brunelli, Matteo
    Franco, Renato
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (02) : 96 - 101
  • [47] The RET proto-oncogene:: a potential target for molecular cancer therapy
    Pützer, BM
    Drosten, M
    TRENDS IN MOLECULAR MEDICINE, 2004, 10 (07) : 351 - 357
  • [48] LEUKEMIC-CELL DIFFERENTIATION AND PROTO-ONCOGENE EXPRESSION
    TASHIMA, M
    SAWADA, H
    OKAZAKI, T
    YUMOTO, Y
    ACTA HAEMATOLOGICA JAPONICA, 1988, 51 (08): : 1490 - 1497
  • [49] Expression of the proto-oncogene Axl in renal cell carcinoma
    Chung, BI
    Malkowicz, SB
    Nguyen, TB
    Libertino, JA
    McGarvey, TW
    DNA AND CELL BIOLOGY, 2003, 22 (08) : 533 - 540
  • [50] Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia
    Linger, Rachel M. A.
    Lee-Sherick, Alisa B.
    DeRyckere, Deborah
    Cohen, Rebecca A.
    Jacobsen, Kristen M.
    McGranahan, Amy
    Brandao, Luis N.
    Winges, Amanda
    Sawczyn, Kelly K.
    Liang, Xiayuan
    Keating, Amy K.
    Tan, Aik Choon
    Earp, H. Shelton
    Graham, Douglas K.
    BLOOD, 2013, 122 (09) : 1599 - 1609
12345